Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ThromboGenics spins out cancer R&D, scales down staff amid lackluster Jetrea sales
ThromboGenics spins out cancer R&D, scales down staff amid lackluster Jetrea sales
ThromboGenics spins out cancer R&D, scales down staff amid lackluster Jetrea sales
Submitted by
admin
on September 1, 2014 - 10:52am
Source:
Fierce Biotech
News Tags:
ThromboGenics
layoffs
R&D
Headline:
ThromboGenics spins out cancer R&D, scales down staff amid lackluster Jetrea sales
Do Not Allow Advertisers to Use My Personal information
